From Cabozantinib to Zanzalintinib: Chemical Tweaks Open New Frontier in Product Hopping
For decades, the pharmaceutical industry’s most familiar strategy for extending the commercial life of a successful medicine has been to ...
Tag: Tyrosine kinase inhibitors
Anlotinib Drives Hepatoblastoma Resistance via GAD1/GABA
Intrinsic drug resistance remains one of the formidable challenges in cancer therapy, often thwarting the efficacy of promising treatments and ...
Tyrosine Kinase and PD-1 Inhibitors Boost Liver Cancer Treatment
In a groundbreaking study poised to reshape therapeutic strategies for hepatocellular carcinoma (HCC), researchers have demonstrated the superior efficacy and ...
Tyrosine Kinase Inhibitors Combat Ewing’s Sarcoma
Ewing’s sarcoma (ES) stands as one of the most aggressive primary bone malignancies, predominantly afflicting children and adolescents. This rare ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!